Precipio, Inc.

PRPO
$22.36 (+ $0.11 + 0.47%)
Last updated: 2026-06-18 02:55 UTC
PRPO Metrics
Exchange
🇺🇸 NASDAQ XNCM
Nasdaq Capital MarketUnited StatesAmerica/New_York
SectorHealthcare
IndustryDiagnostics & Research
ISINUS74019L1070
CUSIP74019L107
Market Price22.36
Dividend Yield N/A
Dividend Growth
1YN/A
3YN/A
5YN/A
10YN/A
Annual Dividend N/A
Latest Payout ($)N/A
Latest Payout DateN/A
Dividend FrequencyNone
P/E RatioN/A
EPS-0.83
Market Cap$41.8M
Book Value7.88
Price to Book3.033
Beta1.09
52w High28.5
52w Low3.9
Next Earnings DateN/A

Precipio, Inc. trades under ticker PRPO on NASDAQ as a stock. Use this page to review stock price, dividends, and price history. The page also shows Healthcare exposure. Identifiers: ISIN US74019L1070, CUSIP 74019L107.

About the Company
Precipio, Inc., a healthcare biotechnology company, provides cancer diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. Precipio, Inc. is based in New Haven, Connecticut.
Price History